StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $65.96MP/E –Yield –

MediciNova profit margin

Profit margin (net margin) is net income as a percentage of revenue.

MediciNova's profit margin for the twelve months ending Jun 30, 2026 was -1168.2%. For fiscal 2025 it was -2928.8%, against -857.2% the year before. The highest annual figure on record is -251.0% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2928.8%−2071.6
FY2023Dec 31, 2023-857.2%−606.1
FY2021Dec 31, 2021-251.0%+123437.3
FY2013Dec 31, 2013-123688.3%−122322.5
FY2012Dec 31, 2012-1365.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-504.8%+1933.0
Q1 FY2026Mar 31, 2026-1383.1%−1310.8
Q4 FY2025Dec 31, 2025-1846.8%+7697.7
Q3 FY2025Sep 30, 2025-2473.6%−2468.9
Q2 FY2025Jun 30, 2025-2437.7%–
Q3 FY2023Sep 30, 2023-72.3%–
Q3 FY2021Sep 30, 2021-9544.4%–
Q1 FY2021Mar 31, 2021-4.7%–

More MediciNova figures

See a number that looks wrong?